Are you Dr. Charas?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
New York, NY 10065Phone+1 212-639-6800
Clinical Trials
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia. Start of enrollment: 2020 Oct 21
- Neoadjuvant Interstitial Brachytherapy Using Diffusing Alpha Emitters Radiation Therapy in Men With Prostate Cancer Start of enrollment: 2022 May 16
Publications & Presentations
PubMed
- 35 citationsPlacement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with palladium-103.Amandeep Taggar, Tomer Charas, Gil'ad N. Cohen, Keeratikarn Boonyawan, Marisa A. Kollmeier
Brachytherapy. 2017-12-11 - 2 citationsImpact of daily soft-tissue image guidance to prostate on pelvic lymph node (PLN) irradiation for prostate patients receiving SBRT.Neelam Tyagi, Elizabeth Hipp, Michelle Cloutier, Tomer Charas, Sandra Fontenla
Journal of Applied Clinical Medical Physics. 2019-07-01 - 3 citationsSecond malignancy risk in prostate cancer and radiotherapy.Tomer Charas, Amandeep Taggar, Michael J. Zelefsky
Future Oncology. 2017-01-17
